MedTrace Logo

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)

NCT01812278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2637

Last updated 2020-07-31

No results posted yet for this study

Summary

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Conditions

  • Smoking

Interventions

BEHAVIORAL

ACT

BEHAVIORAL

CBT

Sponsors & Collaborators

  • Kaiser Permanente

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jonathan Bricker · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-24
Primary Completion
2016-10-26
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812278 on ClinicalTrials.gov